Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT02508727
Eligibility Criteria:
Inclusion Criteria:
* Patients who signed the consent form
* Beneficiaries of the health security system
* No known cardiovascular disease to healthy subjects or patient having a previous heart attack or less proved by cardiac MRI or viability of myocardial scintigraphy performed before. The infarct zone is defined as the area of delayed enhancement cardiac MRI signal in 10-15 minutes after gadolinium injection.
Exclusion Criteria:
* Age \<18 years
* Adult guardianship
* Contraindications to MRI: metallic implants, pacemaker, implantable defibrillator, claustrophobia
* For patients only: Contraindication to Dotarem (renal failure with creatinine clearance \<30 ml / min / 1.73m2 according to MDRD formula, known allergy to gadolinium salts)
* Pregnant and or lactating
* Recent acute coronary syndrome (\<6 weeks)
* Ventricular arrhythmias and supra ventricular significant
* Heart failure stage III-IV NYHA
* Unbalanced severe hypertension (BP\> 160/110 mmHg)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02508727
Study Brief:
Protocol Section:
NCT02508727